Thrombocytopenia after meta-iodobenzylguanidine (MIBG) therapy in neuroblastoma patients may be caused by selective MIBG uptake via the serotonin transporter located on megakaryocytes
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2191-219X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Thrombocytopenia after meta-iodobenzylguanidine (MIBG) therapy in neuroblastoma patients may be caused by selective MIBG uptake via the serotonin transporter located on megakaryocytes ; volume:11 ; number:1 ; day:23 ; month:8 ; year:2021 ; pages:1-10 ; date:12.2021
EJNMMI Research ; 11, Heft 1 (23.8.2021), 1-10, 12.2021
- Creator
-
Blom, Thomas
Meinsma, Rutger
Summa, Franca di
Akker, Emile van den
Kuilenburg, André B. P. van
Hansen, Marten
Tytgat, Godelieve A. M.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13550-021-00823-5
- URN
-
urn:nbn:de:101:1-2021110818314348677924
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:25 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Blom, Thomas
- Meinsma, Rutger
- Summa, Franca di
- Akker, Emile van den
- Kuilenburg, André B. P. van
- Hansen, Marten
- Tytgat, Godelieve A. M.
- SpringerLink (Online service)
Other Objects (12)
Neuroblastoma : mIBG in its diagnosis and management
Selective serotonin reuptake inhibitors (SSRIs) prevent meta-iodobenzylguanidine (MIBG) uptake in platelets without affecting neuroblastoma tumor uptake
Impact of mediastinal, liver and lung 123I-metaiodobenzylguanidine (123I-MIBG) washout on calculated 123I-MIBG myocardial washout
123I metaiodobenzylguanidine (MIBG) uptake predicts early relapse of neuroblastoma using semi-quantitative SPECT/CT analysis
Analysis of quantitative [I-123] mIBG SPECT/CT in a phantom and in patients with neuroblastoma
Evaluating the diagnostic efficacy of whole-body MRI versus 123I-mIBG/131I-mIBG imaging in metastatic pheochromocytoma and paraganglioma
Diagnose des Phäochromozytoms durch Radio-Jod-meta-Jodbenzylguanidin (MIBG)
123I-mIBG scintigraphy in neuroblastoma: development of a SIOPEN semi-quantitative reporting ,method by an international panel
Publisher Correction: Evaluating the diagnostic efficacy of whole-body MRI versus 123I-mIBG/131I-mIBG imaging in metastatic pheochromocytoma and paraganglioma
Untersuchungen zur 123-Jod-meta-Jodbenzylguanidin-(MIBG)-Aufnahme von Humanthrombozyten
A European myocardial 123I-mIBG cross-calibration phantom study
Aurora Kinase A inhibition enhances DNA damage and tumor cell death with 131I-MIBG therapy in high-risk neuroblastoma
Neuroblastoma : mIBG in its diagnosis and management
Selective serotonin reuptake inhibitors (SSRIs) prevent meta-iodobenzylguanidine (MIBG) uptake in platelets without affecting neuroblastoma tumor uptake
Impact of mediastinal, liver and lung 123I-metaiodobenzylguanidine (123I-MIBG) washout on calculated 123I-MIBG myocardial washout
123I metaiodobenzylguanidine (MIBG) uptake predicts early relapse of neuroblastoma using semi-quantitative SPECT/CT analysis
Analysis of quantitative [I-123] mIBG SPECT/CT in a phantom and in patients with neuroblastoma
Evaluating the diagnostic efficacy of whole-body MRI versus 123I-mIBG/131I-mIBG imaging in metastatic pheochromocytoma and paraganglioma
Diagnose des Phäochromozytoms durch Radio-Jod-meta-Jodbenzylguanidin (MIBG)
123I-mIBG scintigraphy in neuroblastoma: development of a SIOPEN semi-quantitative reporting ,method by an international panel
Publisher Correction: Evaluating the diagnostic efficacy of whole-body MRI versus 123I-mIBG/131I-mIBG imaging in metastatic pheochromocytoma and paraganglioma
Untersuchungen zur 123-Jod-meta-Jodbenzylguanidin-(MIBG)-Aufnahme von Humanthrombozyten
A European myocardial 123I-mIBG cross-calibration phantom study
Aurora Kinase A inhibition enhances DNA damage and tumor cell death with 131I-MIBG therapy in high-risk neuroblastoma
Neuroblastoma : mIBG in its diagnosis and management
Selective serotonin reuptake inhibitors (SSRIs) prevent meta-iodobenzylguanidine (MIBG) uptake in platelets without affecting neuroblastoma tumor uptake
Impact of mediastinal, liver and lung 123I-metaiodobenzylguanidine (123I-MIBG) washout on calculated 123I-MIBG myocardial washout
123I metaiodobenzylguanidine (MIBG) uptake predicts early relapse of neuroblastoma using semi-quantitative SPECT/CT analysis
Analysis of quantitative [I-123] mIBG SPECT/CT in a phantom and in patients with neuroblastoma
Evaluating the diagnostic efficacy of whole-body MRI versus 123I-mIBG/131I-mIBG imaging in metastatic pheochromocytoma and paraganglioma
Diagnose des Phäochromozytoms durch Radio-Jod-meta-Jodbenzylguanidin (MIBG)
123I-mIBG scintigraphy in neuroblastoma: development of a SIOPEN semi-quantitative reporting ,method by an international panel
Publisher Correction: Evaluating the diagnostic efficacy of whole-body MRI versus 123I-mIBG/131I-mIBG imaging in metastatic pheochromocytoma and paraganglioma
Untersuchungen zur 123-Jod-meta-Jodbenzylguanidin-(MIBG)-Aufnahme von Humanthrombozyten
A European myocardial 123I-mIBG cross-calibration phantom study